Anastasija Komkova and Thomas Fast from ApHER conducted analyses in a research project examining the healthcare resource utilization and medication burden in epilepsy patients before and after initiating the antiepileptic drug perampanel. The project was presented in a poster at ISPOR 2019 in New Orleans, LA, on May 18-22. Further information and link for the poster [...]
Thomas was a speaker at the Nextlevel Life Sciences Conference in Stockholm in May 2019. During the conference, Thomas shared ApHER´s experience of pooling Nordic data
This Wednesday Thomas Fast attended the 8th National Health Economic Conference in Örebro where he presented some of the work we are doing in ApHER in regards to pooling Nordic data. The conference was held on March 12-13 and it was arranged by the Swedish Health Economic Association (SHEA) in cooporation with Region Örebro county and [...]
Demonstrating the safety profile of a new drug intervention is a pre-requisite for market access. Thomas will introduce the structure of Nordic health register data with a case on how a multi-country safety study was developed to support market access by including health economic aspects in the study design. The Nordic region is regarded as one [...]
Presenting work and receiving feedback is a rewarding part in our scientific work. Thomas Fast presented our Narcolepsy project at the 6th Nordic Narcolepsy Symposium in Uppsala and the project can now move forward with the aim of publishing the results in a scientific journal. Read about the symposium here: https://lnkd.in/d_xAWXE
Prof. Anders Green at the 5th International Conference on Interdisciplinary Management of Diabetes Mellitus and its Complications
Is diabetes per se a risk factor for developing cancer? Or is diabetes a marker of an underlying (pre-clinical) cancer process? Professor Anders Green from ApHER gave an invited presentation exploring these questions at the 5th International Conference on Interdisciplinary Management of Diabetes which took place the 7th to 9th of March in Bucharest, Romania. Read [...]
New publication: Finasteride treatment and male breast cancer: a register-based cohort study in four Nordic countries.
By pooling Nordic health data on medical devices & pharmaceuticals, and analyzing it on the micro-level, we tap into the full potential of big data. The Nordic health registers cover 26 mill. people from birth to death. Read about our most recent safety study, pooling data from 4 Nordic countries, here: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773955/
ApHER participated at ISPOR Europe 2018 and presented a study “COSTS OF MULTIPLE SCLEROSIS IN DENMARK: A REGISTER BASED STUDY”. The unique registers in Denmark allow us to include in the study all individuals with Multiple Sclerosis (MS) in Denmark. All Individuals with MS in 2014 were ascertained and characterized by treatment from the Danish health [...]
Six out of ten of the sclerosis patients who are not in disease-modifying treatment do not attend annual follow-ups. This means that the patients do not receive the symptom management or rehabilitation they need. These results come from a new study by ApHER conducted in collaboration with the Danish Multiple Sclerosis Society, presented by Prof. Anders Green [...]
A poorly regulated diabetes patient is costly for both the public healthcare system and the private insurance companies. In a recent cost-effectiveness study of the LIVA platform ApHER concludes that there is a desirable investment return by managing diabetes patients digitally through online lifestyle coaching. Read the article at LIVA Healthcare here.